You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

  • Technology appraisal guidance
  • Reference number: TA209
  • Published:  24 November 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Insufficient new evidence on increased doses of imatinib for treating GISTs

2010/166 Insufficient new evidence on increased doses of imatinib for treating GISTs

2010/166 Insufficient new evidence on increased doses of imatinib for treating GISTs2010/166 Insufficient new evidence on increased doses of imatinib for treating GISTs
23 November 2010
(72.14 Kb 21 sec @ 28.8Kbps)
Adobe Acrobat reader required.

 Adobe Acrobat reader required.

Back to top